Tissue diagnosis is a vital tool used to diagnose, monitor, and manage different types of cancer. Signs and symptoms of the disease are identified through biopsy, which is a process of taking a sample from an area of interest such as tissue, skin, or tumor for further diagnosis. Biopsy is mainly done to detect cancer or to rule out rejection of transplanted organ draft. It is performed to detect possible causes of both cancerous and non-cancerous tissue, which are unable to be detected via X-rays or CT-scans. Various biopsy procedures are performed depending on the area of sample collection, such as prostate biopsy, liver biopsy, kidney biopsy, skin biopsy, bone marrow biopsy, and endoscopic biopsy, among others. Moreover, Ultrasound biopsy, CT guided biopsy, surgical biopsy, and needle biopsy can be used for tissue diagnostic.
For Requesting a Sample Copy of This Report, Please Visit @
Increasing prevalence or incidence of cancer worldwide is expected to augment the growth of the global tissue diagnostic market during the forecast period. For instance, as reported by the American cancer Society, in 2016, around 1.6 million new cases of cancer were reported in the United States.
Moreover, continuous research for cancer treatment and growing healthcare expenditure is also expected to fuel growth of the global tissue diagnostic market. For instance, in 2015, National Cancer Institute spent around US$ 4,480 million for cancer treatment, which includes uterine cancer, ovarian cancer, leukemia, lung cancer, liver cancer, cervical cancer, colorectal cancer, and breast cancer.
Furthermore, increase in biopsy procedure is expected to boost the market growth. For instance, according to the repost published in the American journal of Nephrology, in 2015, Australia has the highest number of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176) and the U.S. (175).
North America is expected to witness robust growth in the global tissue diagnostic market due to the increasing prevalence of cancer in this region. For instance, aaccording to the Centres of Disease Control and Prevention (CDC), in the U.S., over 1600 people a day, died due to the cause of cancer, between 1999 and 2014. Moreover, aaccording to the National cancer institute and CDC, the prevalence of prostate cancer is high in male, while breast cancer (in females) are most dominated, followed by colon and lung cancer in both male and female.
Request a PDF Brochure with Latest Insights @
Major players active in the global tissue diagnostic market are Abbott laboratories, Danaher corp., Life Technologies, Biogenex Laboratories, Roche Diagnostics, Sigma-Aldrich, Thermo Fisher Scientific, Agilent technologies, and Biocare Medical.
In May 2019, Roche announced the global launch of the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, a first in vitro diagnostic ROS1 immunohistochemistry (IHC) assay. The test detects the presence of ROS1 protein in tissue, and may be useful in identifying ROS1-positive cancer cases.
In February 2019, Lunaphore Technologies announced the launch of LabSat to detect specific cancer biomarkers in tissue samples taken from cancer patients.
In July 2018, Aquaro Histology announced the launch of the Aquaro Wishbone blade handling tool, a handheld tool that allows histologists to change and align microtome blades without touching the blade.
By Product Type:
- In Situ Hybridization
- Digital Pathology
- Breast Cancer
- Lymphoma Cancer
- Gastric Cancer
By End User:
- Research Laboratories
- Contract Research Organizations
Reasons to Purchase this Report
• Current and future of global Tissue Diagnostic market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Tissue Diagnostic Market Research Report
Section 1: Global Tissue Diagnostic Industry Overview
Section 2: Global Economic Impact on Tissue Diagnostic Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Tissue Diagnostic Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027